Global Microneedle Transdermal Drug Delivery System Market Research Report 2023

Publication ID:

PB510233873

Publication Date:

October 20, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Microneedle Transdermal Drug Delivery System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Microneedle Transdermal Drug Delivery System 91制片厂.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Microneedle Transdermal Drug Delivery System market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
3 M
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG
Segment by Type
Hollow Type
Solid Type
Soluble Type
Segment by Application
Drug
Vaccine
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Microneedle Transdermal Drug Delivery System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Microneedle Transdermal Drug Delivery System Market Overview
1.1 Product Overview and Scope of Microneedle Transdermal Drug Delivery System
1.2 Microneedle Transdermal Drug Delivery System Segment by Type
1.2.1 Global Microneedle Transdermal Drug Delivery System Market Value Comparison by Type (2023-2029)
1.2.2 Hollow Type
1.2.3 Solid Type
1.2.4 Soluble Type
1.3 Microneedle Transdermal Drug Delivery System Segment by Application
1.3.1 Global Microneedle Transdermal Drug Delivery System Market Value by Application: (2023-2029)
1.3.2 Drug
1.3.3 Vaccine
1.4 Global Microneedle Transdermal Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Microneedle Transdermal Drug Delivery System Revenue 2018-2029
1.4.2 Global Microneedle Transdermal Drug Delivery System Sales 2018-2029
1.4.3 Global Microneedle Transdermal Drug Delivery System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Microneedle Transdermal Drug Delivery System Market Competition by Manufacturers
2.1 Global Microneedle Transdermal Drug Delivery System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Microneedle Transdermal Drug Delivery System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Microneedle Transdermal Drug Delivery System Average Price by Manufacturers (2018-2023)
2.4 Global Microneedle Transdermal Drug Delivery System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Microneedle Transdermal Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microneedle Transdermal Drug Delivery System, Product Type & Application
2.7 Microneedle Transdermal Drug Delivery System Market Competitive Situation and Trends
2.7.1 Microneedle Transdermal Drug Delivery System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microneedle Transdermal Drug Delivery System Players Market Share by Revenue
2.7.3 Global Microneedle Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microneedle Transdermal Drug Delivery System Retrospective Market Scenario by Region
3.1 Global Microneedle Transdermal Drug Delivery System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Microneedle Transdermal Drug Delivery System Global Microneedle Transdermal Drug Delivery System Sales by Region: 2018-2029
3.2.1 Global Microneedle Transdermal Drug Delivery System Sales by Region: 2018-2023
3.2.2 Global Microneedle Transdermal Drug Delivery System Sales by Region: 2024-2029
3.3 Global Microneedle Transdermal Drug Delivery System Global Microneedle Transdermal Drug Delivery System Revenue by Region: 2018-2029
3.3.1 Global Microneedle Transdermal Drug Delivery System Revenue by Region: 2018-2023
3.3.2 Global Microneedle Transdermal Drug Delivery System Revenue by Region: 2024-2029
3.4 North America Microneedle Transdermal Drug Delivery System Market Facts & Figures by Country
3.4.1 North America Microneedle Transdermal Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Microneedle Transdermal Drug Delivery System Sales by Country (2018-2029)
3.4.3 North America Microneedle Transdermal Drug Delivery System Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Microneedle Transdermal Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe Microneedle Transdermal Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Microneedle Transdermal Drug Delivery System Sales by Country (2018-2029)
3.5.3 Europe Microneedle Transdermal Drug Delivery System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microneedle Transdermal Drug Delivery System Market Facts & Figures by Country
3.6.1 Asia Pacific Microneedle Transdermal Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Microneedle Transdermal Drug Delivery System Sales by Country (2018-2029)
3.6.3 Asia Pacific Microneedle Transdermal Drug Delivery System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Microneedle Transdermal Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America Microneedle Transdermal Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Microneedle Transdermal Drug Delivery System Sales by Country (2018-2029)
3.7.3 Latin America Microneedle Transdermal Drug Delivery System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microneedle Transdermal Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Microneedle Transdermal Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Microneedle Transdermal Drug Delivery System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Microneedle Transdermal Drug Delivery System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microneedle Transdermal Drug Delivery System Sales by Type (2018-2029)
4.1.1 Global Microneedle Transdermal Drug Delivery System Sales by Type (2018-2023)
4.1.2 Global Microneedle Transdermal Drug Delivery System Sales by Type (2024-2029)
4.1.3 Global Microneedle Transdermal Drug Delivery System Sales Market Share by Type (2018-2029)
4.2 Global Microneedle Transdermal Drug Delivery System Revenue by Type (2018-2029)
4.2.1 Global Microneedle Transdermal Drug Delivery System Revenue by Type (2018-2023)
4.2.2 Global Microneedle Transdermal Drug Delivery System Revenue by Type (2024-2029)
4.2.3 Global Microneedle Transdermal Drug Delivery System Revenue Market Share by Type (2018-2029)
4.3 Global Microneedle Transdermal Drug Delivery System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Microneedle Transdermal Drug Delivery System Sales by Application (2018-2029)
5.1.1 Global Microneedle Transdermal Drug Delivery System Sales by Application (2018-2023)
5.1.2 Global Microneedle Transdermal Drug Delivery System Sales by Application (2024-2029)
5.1.3 Global Microneedle Transdermal Drug Delivery System Sales Market Share by Application (2018-2029)
5.2 Global Microneedle Transdermal Drug Delivery System Revenue by Application (2018-2029)
5.2.1 Global Microneedle Transdermal Drug Delivery System Revenue by Application (2018-2023)
5.2.2 Global Microneedle Transdermal Drug Delivery System Revenue by Application (2024-2029)
5.2.3 Global Microneedle Transdermal Drug Delivery System Revenue Market Share by Application (2018-2029)
5.3 Global Microneedle Transdermal Drug Delivery System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 3 M
6.1.1 3 M Corporation Information
6.1.2 3 M Description and Business Overview
6.1.3 3 M Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 3 M Microneedle Transdermal Drug Delivery System Product Portfolio
6.1.5 3 M Recent Developments/Updates
6.2 Zosano Pharma
6.2.1 Zosano Pharma Corporation Information
6.2.2 Zosano Pharma Description and Business Overview
6.2.3 Zosano Pharma Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Zosano Pharma Microneedle Transdermal Drug Delivery System Product Portfolio
6.2.5 Zosano Pharma Recent Developments/Updates
6.3 Becton-Dickinson(BD)Technologies
6.3.1 Becton-Dickinson(BD)Technologies Corporation Information
6.3.2 Becton-Dickinson(BD)Technologies Description and Business Overview
6.3.3 Becton-Dickinson(BD)Technologies Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Becton-Dickinson(BD)Technologies Microneedle Transdermal Drug Delivery System Product Portfolio
6.3.5 Becton-Dickinson(BD)Technologies Recent Developments/Updates
6.4 Nanopass Technologies
6.4.1 Nanopass Technologies Corporation Information
6.4.2 Nanopass Technologies Description and Business Overview
6.4.3 Nanopass Technologies Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nanopass Technologies Microneedle Transdermal Drug Delivery System Product Portfolio
6.4.5 Nanopass Technologies Recent Developments/Updates
6.5 Corium
6.5.1 Corium Corporation Information
6.5.2 Corium Description and Business Overview
6.5.3 Corium Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Corium Microneedle Transdermal Drug Delivery System Product Portfolio
6.5.5 Corium Recent Developments/Updates
6.6 Valeritas
6.6.1 Valeritas Corporation Information
6.6.2 Valeritas Description and Business Overview
6.6.3 Valeritas Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Valeritas Microneedle Transdermal Drug Delivery System Product Portfolio
6.6.5 Valeritas Recent Developments/Updates
6.7 Nitto
6.6.1 Nitto Corporation Information
6.6.2 Nitto Description and Business Overview
6.6.3 Nitto Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nitto Microneedle Transdermal Drug Delivery System Product Portfolio
6.7.5 Nitto Recent Developments/Updates
6.8 Microdermics
6.8.1 Microdermics Corporation Information
6.8.2 Microdermics Description and Business Overview
6.8.3 Microdermics Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Microdermics Microneedle Transdermal Drug Delivery System Product Portfolio
6.8.5 Microdermics Recent Developments/Updates
6.9 TheraJect, Inc
6.9.1 TheraJect, Inc Corporation Information
6.9.2 TheraJect, Inc Description and Business Overview
6.9.3 TheraJect, Inc Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 TheraJect, Inc Microneedle Transdermal Drug Delivery System Product Portfolio
6.9.5 TheraJect, Inc Recent Developments/Updates
6.10 Vaxxas
6.10.1 Vaxxas Corporation Information
6.10.2 Vaxxas Description and Business Overview
6.10.3 Vaxxas Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Vaxxas Microneedle Transdermal Drug Delivery System Product Portfolio
6.10.5 Vaxxas Recent Developments/Updates
6.11 Lohmann Therapie-Systeme AG
6.11.1 Lohmann Therapie-Systeme AG Corporation Information
6.11.2 Lohmann Therapie-Systeme AG Microneedle Transdermal Drug Delivery System Description and Business Overview
6.11.3 Lohmann Therapie-Systeme AG Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Lohmann Therapie-Systeme AG Microneedle Transdermal Drug Delivery System Product Portfolio
6.11.5 Lohmann Therapie-Systeme AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microneedle Transdermal Drug Delivery System Industry Chain Analysis
7.2 Microneedle Transdermal Drug Delivery System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microneedle Transdermal Drug Delivery System Production Mode & Process
7.4 Microneedle Transdermal Drug Delivery System Sales and Marketing
7.4.1 Microneedle Transdermal Drug Delivery System Sales Channels
7.4.2 Microneedle Transdermal Drug Delivery System Distributors
7.5 Microneedle Transdermal Drug Delivery System Customers
8 Microneedle Transdermal Drug Delivery System Market Dynamics
8.1 Microneedle Transdermal Drug Delivery System Industry Trends
8.2 Microneedle Transdermal Drug Delivery System Market Drivers
8.3 Microneedle Transdermal Drug Delivery System Market Challenges
8.4 Microneedle Transdermal Drug Delivery System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

3 M
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.